Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for bronchoscopy sedation
CTR20200931Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remimazolam in None, sponsored by Hengrui Therapeutics. Started May 2020; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on CTR20200931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200931.